Home
About
Overview
Sharing Data
ORCID
Help
History (17)
A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo.
Insurance Claim Review
Signal Processing, Computer-Assisted
Non-Neuronal Cholinergic System
SOFT trial can be very hard on young women.
See All 17 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
SOFT trial can be very hard on young women.
Layeequr Rahman R, Baker T, Crawford S, Kauffman R. SOFT trial can be very hard on young women. Breast. 2015 Dec; 24(6):767-8.
View in:
PubMed
subject areas
Adult
Amenorrhea
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Female
Humans
Ovary
Patient Compliance
Tamoxifen
authors with profiles
Sybil L Crawford PhD